Arvinas, Inc. (ARVN)
13.14
+0.77
(+6.22%)
USD |
NASDAQ |
Feb 25, 14:45
Arvinas Market Cap : 843.91M for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 153.63B |
| ACADIA Pharmaceuticals, Inc. | 4.219B |
| Alnylam Pharmaceuticals, Inc. | 43.60B |
| Savara, Inc. | 1.190B |
| BioMarin Pharmaceutical, Inc. | 11.86B |
Market Cap Related Metrics
| PS Ratio | 3.550 |
| Price to Book Value | 1.945 |
| Price | 13.14 |
| Earnings Yield | -9.25% |